TEVA

TEVA Total Debt

$16.87BQuarterly · USD

Period ending:

TEVA FY Total DebtUSD
TEVA FY Total Debt1986-03-31: $39.80M1987-03-31: $35.90M1988-12-31: $74.30M1989-12-31: $91.40M1990-12-31: $124.00M1991-12-31: $115.00M1992-12-31: $133.70M1993-12-31: $178.60M1994-12-31: $219.10M1995-12-31: $291.20M1996-12-31: $502.30M1997-12-31: $369.70M1998-12-31: $526.20M1999-12-31: $667.68M2000-12-31: $1.16B2001-12-31: $1.45B2002-12-31: $1.90B2003-12-31: $1.46B2004-12-31: $2.07B2005-12-31: $2.15B2006-12-31: $5.33B2007-12-31: $5.19B2008-12-31: $8.44B2009-12-31: $6.34B2010-12-31: $5.53B2011-12-31: $14.52B2012-12-31: $14.72B2013-12-31: $12.19B2014-12-31: $10.33B2015-12-31: $9.97B2016-12-31: $35.80B2017-12-31: $32.48B2018-12-31: $28.92B2019-12-31: $27.34B2020-12-31: $26.40B2021-12-31: $23.46B2022-12-31: $21.56B2023-12-31: $20.15B2024-12-31: $18.08B2025-12-31: $17.38B$35.80B$0.00
1986-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TEVA total debt history

Sum of short-term and long-term debt obligations. The available annual fiscal periods series contains 40 observations from Mar 31, 1986 to Dec 31, 2025.

Teva Pharmaceutical Industries Limited American Depositary Shares Total Debt — Annual fiscal periods (USD)
Period endingTotal Debt (USD)
17,381,731,000
18,079,000,000
20,153,000,000
21,561,000,000
23,459,000,000
26,398,000,000
27,342,000,000
28,916,000,000
32,475,000,000
35,800,000,000
9,968,000,000
10,327,000,000
12,191,000,000
14,718,000,000
14,516,000,000
5,529,000,000
6,339,000,000
8,443,000,000
5,188,000,000
5,327,000,000
2,148,800,000
2,073,800,000
1,459,600,000
1,899,900,000
1,453,399,000
1,155,414,000
667,678,000
526,200,000
369,700,000
502,300,000
291,200,000
219,100,000
178,600,000
133,700,000
115,000,000
124,000,000
91,400,000
74,300,000
35,900,000
39,800,000

Compare total debt

All TEVA financial metrics · TEVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.